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The effect of intrapartum glycemic control on the incidence of neonatal hypoglycemia  
Signe Caksa, BS, Amanda Roman, MD* 
 
Introduction: 1-2% and 6-9% of pregnancies are complicated by type I/II and gestational 
diabetes mellitus (DM), respectively, leading to increased risk of adverse neonatal outcomes. 
Women with DM require glucose monitoring and glycemic control at the time of delivery; 
however, it remains unclear how variations in intrapartum glucose impact neonatal 
hypoglycemia.  
Methods: This is a retrospective cohort study of women with singleton pregnancies, diagnosed 
with DM, who delivered >36 weeks gestation after attempting induction of labor at Thomas 
Jefferson University Hospital between 01/01/2017 and 01/01/2018. Intrapartum DM 
management included hourly capillary glucose (CG) monitoring until delivery, insulin drip with 
CG>110mg/dL and dextrose with CG<60mg/dL. Poor intrapartum glycemic control and neonatal 
hypoglycemia was defined as CG100mg/dL and CG<40mg/dL, respectively. Maternal 
characteristics, perinatal outcomes, and intrapartum CG values were collected. Primary outcomes 
included neonatal hypoglycemia. Average intrapartum CG 6-hours before delivery was used to 
evaluate neonatal hypoglycemia risk. 
Results: Data included 67 women with DM (mean age 326 years, mean BMI 31.98.1) who 
delivered at mean gestational age 38.22.2 weeks. Mean birthweight was 3188605g; 16.4% and 
3.0% of neonates had Apgar scores <7 at 1- and 5-minutes, respectively, and 29.9% were 
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admitted to the intensive care unit (ICN). Neonatal hypoglycemia was present in n=9 (13.4%) 
and was higher in women with poor intrapartum glycemic control (66.7% vs. 31.0%, OR=2.15).  
Conclusion: Poor glucose control in women with DM 6-hours before delivery may be associated 
with increased incidence of neonatal hypoglycemia. Future prospective studies could examine 
whether strict intrapartum glycemic control lowers neonatal hypoglycemia. 
  
